Bandingkan Harga & Kinerja Ekadharma International Tbk. (EKAD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ekadharma International Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Ekadharma International Tbk. diperdagangkan di Rp300 (kapitalisasi pasar 838,53 M, volume 24 jam 43,26 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Ekadharma International Tbk. jauh lebih besar — sekitar 5,1× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Ekadharma International Tbk. lebih aktif diperdagangkan (43,26 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| EKAD | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 838,53 M | 164,65 M |
Volume | 43,26 jt | 187,4 rb |
Lot | 432,59 rb | 1,87 rb |
Perputaran | 12,97 M | 44,35 jt |
Harga Rata-rata | 299,83 | 236,67 |
Nilai Transaksi | 12,97 M | 44,35 jt |
Harga Ekuilibrium Indikatif | 300 | 242 |
Volume Ekuilibrium Indikatif | 3,19 rb | 500 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ekadharma International Tbk.
PT Ekadharma International Tbk (the Company) was established under the name of PT Ekadharma Widya Graphika based on Notarial Deed No. 71 dated November 20, 1981. PT Ekadharma Tape Industries Tbk manufactures computer continuous form paper and other related products. It also holds a manufacturing and distribution license from Nashua Corporation, USA.In August 2, 2006, The company's name was changed to PT Ekadharma International Tbk.
Selengkapnya di halaman EKAD →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
